Atara Biotherapeutics, Inc. (ATRA)
9.76
+0.23
(+2.41%)
USD |
NASDAQ |
Sep 04, 16:00
10.34
+0.58
(+5.94%)
After-Hours: 20:00
Atara Biotherapeutics Total Liabilities (Quarterly) : 58.02M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.02M |
| March 31, 2026 | 57.31M |
| December 31, 2025 | 60.39M |
| September 30, 2025 | 66.80M |
| June 30, 2025 | 71.94M |
| March 31, 2025 | 117.11M |
| December 31, 2024 | 206.38M |
| September 30, 2024 | 233.24M |
| June 30, 2024 | 228.15M |
| March 31, 2024 | 263.58M |
| December 31, 2023 | 264.74M |
| September 30, 2023 | 239.63M |
| June 30, 2023 | 238.98M |
| March 31, 2023 | 237.12M |
| December 31, 2022 | 249.78M |
| September 30, 2022 | 181.20M |
| June 30, 2022 | 178.64M |
| March 31, 2022 | 172.96M |
| December 31, 2021 | 188.51M |
| September 30, 2021 | 139.78M |
| June 30, 2021 | 125.25M |
| March 31, 2021 | 130.60M |
| December 31, 2020 | 125.78M |
| September 30, 2020 | 51.60M |
| June 30, 2020 | 46.99M |
| Date | Value |
|---|---|
| March 31, 2020 | 46.72M |
| December 31, 2019 | 52.16M |
| September 30, 2019 | 46.34M |
| June 30, 2019 | 41.86M |
| March 31, 2019 | 40.79M |
| December 31, 2018 | 52.98M |
| September 30, 2018 | 39.89M |
| June 30, 2018 | 40.21M |
| March 31, 2018 | 33.92M |
| December 31, 2017 | 39.92M |
| September 30, 2017 | 23.74M |
| June 30, 2017 | 23.01M |
| March 31, 2017 | 8.604M |
| December 31, 2016 | 10.18M |
| September 30, 2016 | 14.22M |
| June 30, 2016 | 10.57M |
| March 31, 2016 | 9.144M |
| December 31, 2015 | 9.875M |
| September 30, 2015 | 6.631M |
| June 30, 2015 | 11.85M |
| March 31, 2015 | 3.723M |
| December 31, 2014 | 2.94M |
| September 30, 2014 | 2.577M |
| June 30, 2014 | 2.284M |
| March 31, 2014 | 2.998M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.02M |
| Shareholders Equity (Quarterly) | -37.00M |
| Debt to Equity Ratio | -1.390 |
| Current Ratio | 1.976 |
| Net Debt Paydown Yield | 5.36% |